Filing metadata

Accession number
0000899243-22-011086
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Mar 15, 2022
Reporting period
Feb 28, 2022
Description
Insider transaction

Explore SEC Filings Hub